Pontes J E, Ohe H, Watanabe H, Murphy G P
Cancer. 1984 Mar 15;53(6):1369-72. doi: 10.1002/1097-0142(19840315)53:6<1369::aid-cncr2820530625>3.0.co;2-y.
Transrectal prostatic ultrasonography has been performed in 203 patients within the last year. This new diagnostic modality has proven reliable in quantitating decrease in volume of the primary tumor following therapy in 71% of patients with prostatic carcinoma (10 of 14 patients) in whom long-term follow-up is available. In 12 patients staged prior to radical prostatectomy, prostatic ultrasonography was extremely valuable in detecting capsular involvement. This new diagnostic modality has significantly enhanced the staging capabilities in patients with localized prostatic carcinoma.
去年对203例患者进行了经直肠前列腺超声检查。这种新的诊断方法已被证明在71%的前列腺癌患者(14例中的10例)中,对于定量治疗后原发肿瘤体积的减小是可靠的,这些患者可进行长期随访。在12例接受根治性前列腺切除术之前进行分期的患者中,前列腺超声检查在检测包膜受累方面极具价值。这种新的诊断方法显著提高了局限性前列腺癌患者的分期能力。